Internal Medicine News
-
The average meal at a chain restaurant contains more than half the calories, 1.5 times as much sodium and almost all the fat that people are recommended to consume in an entire day, researchers in Canada found.
-
GlaxoSmithKline Plc and Theravance Inc.’s Breo Ellipta should be approved to treat a lung disorder that is the third-leading cause of death in the U.S., advisers to the Food and Drug Administration said.
-
Mark Moy came to the U.S. from China, paid his way through medical school at the University of Illinois in the 1970s and became an emergency room physician.
-
More than three-quarters of U.S. medical students continue to shun primary care for higher-paying specialties, setting the stage for a shortage of doctors as the population ages and health care expands, a study found.
-
A mammogram every other year reduces the risk that most women will be incorrectly told they may have breast cancer, without increasing the odds they will be diagnosed with advanced disease, researchers said.
-
Almost one-fourth of doctors are unable to accommodate and treat patients who use wheelchairs more than 20 years after the passing of the Americans with Disabilities Act, a study found.
-
People taking diabetes drugs such as Merck & Co.’s Januvia were affected by pancreatic cell growth and damage that may turn cancerous, a small study found.
-
Older U.S. adults may get too many colonoscopies, costing Medicare an estimated $500 million a year and putting patients at an increased risk of side effects such as bleeding, researchers found.
-
States with the most laws regulating firearms, including Massachusetts and New York, have the lowest gun-death rates from homicides and suicides, according to a study published by the American Medical Association.
-
Diabetes drugs sold by Merck & Co. and Bristol-Myers Squibb Co. may double a user’s risk of developing an inflammation of the pancreas linked to cancer and kidney failure, an analysis of insurance records shows.
|
|
Most Popular on Bloomberg
|
| |